Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29872435)

  • 1. SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction.
    Fernandes S; Srivastava N; Sudan R; Middleton FA; Shergill AK; Ryan JC; Kerr WG
    Front Immunol; 2018; 9():1100. PubMed ID: 29872435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of SHIP1 expression and activity in Crohn's disease patients.
    Somasundaram R; Fernandes S; Deuring JJ; de Haar C; Kuipers EJ; Vogelaar L; Middleton FA; van der Woude CJ; Peppelenbosch MP; Kerr WG; Fuhler GM
    PLoS One; 2017; 12(8):e0182308. PubMed ID: 28767696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.
    Nunes de Miranda SM; Wilhelm T; Huber M; Zorn CN
    Cell Commun Signal; 2016 May; 14(1):12. PubMed ID: 27206658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
    Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
    J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
    Ngoh EN; Weisser SB; Lo Y; Kozicky LK; Jen R; Brugger HK; Menzies SC; McLarren KW; Nackiewicz D; van Rooijen N; Jacobson K; Ehses JA; Turvey SE; Sly LM
    Gastroenterology; 2016 Feb; 150(2):465-76. PubMed ID: 26481854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice.
    Park MY; Srivastava N; Sudan R; Viernes DR; Chisholm JD; Engelman RW; Kerr WG
    Mucosal Immunol; 2014 Nov; 7(6):1429-1439. PubMed ID: 24781051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
    Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage-specific regulation of allergic airway inflammation by the lipid phosphatase Src homology 2 domain-containing inositol 5-phosphatase (SHIP-1).
    Gold MJ; Hughes MR; Antignano F; Hirota JA; Zaph C; McNagny KM
    J Allergy Clin Immunol; 2015 Sep; 136(3):725-736.e2. PubMed ID: 25746967
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Olufunmilayo EO; Holsinger RMD
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice.
    Dobranowski PA; Tang C; Sauvé JP; Menzies SC; Sly LM
    Gut Microbes; 2019; 10(5):578-598. PubMed ID: 30760087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy.
    Nguyen HT; Dalmasso G; Müller S; Carrière J; Seibold F; Darfeuille-Michaud A
    Gastroenterology; 2014 Feb; 146(2):508-19. PubMed ID: 24148619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crohn's disease-associated polymorphism in ATG16L1 (rs2241880) reduces SHIP gene expression and activity in human subjects.
    Ngoh EN; Brugger HK; Monajemi M; Menzies SC; Hirschfeld AF; Del Bel KL; Jacobson K; Lavoie PM; Turvey SE; Sly LM
    Genes Immun; 2015 Oct; 16(7):452-61. PubMed ID: 26226011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
    Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy.
    Kosoy R; Kim-Schulze S; Rahman A; Friedman JR; Huang R; Peters LA; Amir EA; Perrigoue J; Stojmirovic A; Song WM; Ke H; Ungaro R; Mehandru S; Cho J; Dubinsky M; Curran M; Brodmerkel C; Schadt EE; Sands BE; Colombel JF; Kasarskis A; Argmann CA; Suárez-Fariñas M
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):599-632. PubMed ID: 33813036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.
    Neubauer K; Woźniak-Stolarska B; Krzystek-Korpacka M
    Biomed Res Int; 2018; 2018():4961753. PubMed ID: 30515402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
    PLoS One; 2017; 12(8):e0179710. PubMed ID: 28817680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
    Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
    Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.